Skip to Content

56,683 Results Found

  • Article
  • Open Access
9 Citations
2,402 Views
13 Pages

External Validation of the SERC Trial Population: Comparison with the Multicenter French Cohort, the Swedish and SENOMIC Trial Populations for Breast Cancer Patients with Sentinel Node Micro-Metastasis

  • Gilles Houvenaeghel,
  • Houssein El Hajj,
  • Julien Barrou,
  • Monique Cohen,
  • Pédro Raro,
  • Jérémy De Troyer,
  • Pierre Gimbergues,
  • Christine Tunon de Lara,
  • Vivien Ceccato and
  • the SERC Trial Group
  • + 10 authors

11 October 2020

Many trials confirmed the safety of omitting axillary dissection in the selected patients treated for early breast cancer. The external validity of these trials is questionable. Our study aimed to evaluate the accuracy of the French population repres...

  • Study Protocol
  • Open Access
12 Citations
5,342 Views
14 Pages

Rationale and Design of BeatNF2 Trial: A Clinical Trial to Assess the Efficacy and Safety of Bevacizumab in Patients with Neurofibromatosis Type 2 Related Vestibular Schwannoma

  • Masazumi Fujii,
  • Masao Kobayakawa,
  • Kiyoshi Saito,
  • Akihiro Inano,
  • Akio Morita,
  • Mitsuhiro Hasegawa,
  • Akitake Mukasa,
  • Takafumi Mitsuhara,
  • Takeo Goto and
  • on behalf of the BeatNF2 Trial Investigators
  • + 7 authors

31 January 2021

Neurofibromatosis type 2 (NF2) causes bilateral vestibular schwannomas (VSs), leading to deafness. VS is treated by surgery or radiation, but neither treatments prevent hearing loss. Bevacizumab was found to be effective in suppressing the tumor’s gr...

  • Article
  • Open Access
363 Views
15 Pages

The Trial of Intraoperative Cell Salvage Versus Transfusion in Ovarian Cancer (TIC TOC): Results of a Randomized Controlled Feasibility Study

  • Khadra Galaal,
  • Patricia Jane Vickery,
  • Elsa Marques,
  • Joanne Palmer,
  • Benjamin Jones,
  • Emma O’Shaughnessy,
  • Alberto Lopes,
  • Paul Ewings,
  • Ruud L. M. Bekkers and
  • The TIC TOC Trial Group

22 February 2026

Objectives: To evaluate the acceptability and feasibility of intraoperative cell salvage (ICS) in women with ovarian cancer. A prospective multicenter randomized controlled feasibility trial. Setting: Four U.K. cancer centers. Women FIGO stage III/IV...

  • Article
  • Open Access
3 Citations
8,163 Views
8 Pages

Placebo by Proxy in Neonatal Randomized Controlled Trials: Does It Matter?

  • Tiziana L. Burkart,
  • Andrea Kraus,
  • Brigitte Koller,
  • Giancarlo Natalucci,
  • Beatrice Latal,
  • Jean-Claude Fauchère,
  • Hans Ulrich Bucher,
  • Christoph M. Rüegger and
  • For the Swiss EPO Neuroprotection Trial Group

Placebo effects emerging from the expectations of relatives, also known as placebo by proxy, have seldom been explored. The aim of this study was to investigate whether in a randomized controlled trial (RCT) there is a clinically relevant difference...

  • Article
  • Open Access
2,164 Views
11 Pages

Sleep Deprivation Influences Trial-to-Trial Transfer but Not Task Performance

  • Bingyao Shen,
  • Zhiqiang Tian,
  • Jiajia Li,
  • Yu Sun,
  • Yi Xiao and
  • Rixin Tang

20 September 2022

Previous research has shown that sleep deprivation can affect emotions and some cognitive functions. However, research on how sleep deprivation influences the visuomotor memory have rarely been reported. In the current study, a Fitts’ Law task...

  • Article
  • Open Access
13 Citations
7,003 Views
12 Pages

Effect of Functional Electrical Stimulation in Convalescent Stroke Patients: A Multicenter, Randomized Controlled Trial

  • Shuji Matsumoto,
  • Megumi Shimodozono,
  • Tomokazu Noma,
  • Kodai Miyara,
  • Tetsuya Onoda,
  • Rina Ijichi,
  • Takashi Shigematsu,
  • Akira Satone,
  • Hidenobu Okuma and
  • the RALLY Trial Investigators
  • + 5 authors

1 April 2023

Background: We evaluated whether the Walkaide® device could effectively improve walking ability and lower extremity function in post-stroke patients with foot drop. Patients aged 20–85 years with an initial stroke within ≤6 months and a...

  • Article
  • Open Access
6 Citations
3,810 Views
14 Pages

Engaging Patients in Smoking Cessation Treatment within the Lung Cancer Screening Setting: Lessons Learned from an NCI SCALE Trial

  • Randi M. Williams,
  • Ellie Eyestone,
  • Laney Smith,
  • Joanna G. Philips,
  • Julia Whealan,
  • Marguerite Webster,
  • Tengfei Li,
  • George Luta,
  • Kathryn L. Taylor and
  • on behalf of the Lung Screening, Tobacco, Health Trial

23 March 2022

Offering smoking cessation treatment at lung cancer screening (LCS) will maximize mortality reduction associated with screening, but predictors of treatment engagement are not well understood. We examined participant characteristics of engagement in...

  • Article
  • Open Access
6 Citations
3,957 Views
17 Pages

Collaborative Studies for the Detection of Taenia spp. Infections in Humans within CYSTINET, the European Network on Taeniosis/Cysticercosis

  • María Ángeles Gómez-Morales,
  • Patrizio Pezzotti,
  • Alessandra Ludovisi,
  • Belgees Boufana,
  • Pierre Dorny,
  • Titia Kortbeek,
  • Joachim Blocher,
  • Veronika Schmidt,
  • Marco Amati and
  • The Ring Trial Participants
  • + 3 authors

Laboratory tools for diagnosing taeniosis/cysticercosis in non-endemic countries are available; however, there is little data on their performance. To provide information on the sensitivity, specificity, and reproducibility of these tools, inter-labo...

  • Article
  • Open Access
1 Citations
1,207 Views
14 Pages

Measuring What Matters in Trial Operations: Development and Validation of the Clinical Trial Site Performance Measure

  • Mattia Bozzetti,
  • Alessio Lo Cascio,
  • Daniele Napolitano,
  • Nicoletta Orgiana,
  • Vincenzina Mora,
  • Stefania Fiorini,
  • Giorgia Petrucci,
  • Francesca Resente,
  • Irene Baroni and
  • Monica Guberti
  • + 1 author

26 September 2025

Background/Objectives: The execution of clinical trials is increasingly constrained by operational complexity, regulatory requirements, and variability in site performance. These challenges have direct implications for the reliability of trial outcom...

  • Article
  • Open Access
51 Citations
20,017 Views
20 Pages

Adherence to Ketogenic and Mediterranean Study Diets in a Crossover Trial: The Keto–Med Randomized Trial

  • Matthew J. Landry,
  • Anthony Crimarco,
  • Dalia Perelman,
  • Lindsay R. Durand,
  • Christina Petlura,
  • Lucia Aronica,
  • Jennifer L. Robinson,
  • Sun H. Kim and
  • Christopher D. Gardner

17 March 2021

Adherence is a critical factor to consider when interpreting study results from randomized clinical trials (RCTs) comparing one diet to another, but it is frequently not reported by researchers. The purpose of this secondary analysis of the Keto–Med...

  • Protocol
  • Open Access
1 Citations
7,566 Views
14 Pages

A Randomised Controlled Trial of YOGa and Strengthening Exercise for Knee OsteoArthritis: Protocol for a Comparative Effectiveness Trial (YOGA Trial)

  • Ambrish Singh,
  • Dawn Aitken,
  • Steffany Moonaz,
  • Andrew J. Palmer,
  • Leigh Blizzard,
  • Changhai Ding,
  • Stan Drummen,
  • Graeme Jones,
  • Kim Bennell and
  • Benny Antony

Osteoarthritis (OA) is a common joint disorder for which there is no cure. Current treatments are suboptimal. Exercise is a core treatment for knee OA, with muscle strengthening exercise commonly recommended. Yoga is a mind-body exercise intervention...

  • Article
  • Open Access
8 Citations
3,373 Views
15 Pages

Clinical Predictors of Early Trial Discontinuation for Patients Participating in Phase I Clinical Trials in Oncology

  • Joeri A. J. Douma,
  • Laurien M. Buffart,
  • Ramy Sedhom,
  • Mariette Labots,
  • Willemien C. Menke-van der Houven van Oordt,
  • Mikkjal Skardhamar,
  • Anthony De Felice,
  • Esther Lee,
  • Divya Dharmaraj and
  • Henk M. W. Verheul
  • + 2 authors

11 May 2021

Despite stringent eligibility criteria for trial participation, early discontinuation often occurs in phase I trials. To better identify patients unlikely to benefit from phase I trials, we investigated predictors for early trial discontinuation. Dat...

  • Protocol
  • Open Access
2,774 Views
10 Pages

28 September 2023

Chronic wound management is a global challenge. Millions of patients suffer from nonhealing ulcers and health systems are overwhelmed by the growing demand for treatment. Despite the prevalence of chronic wounds, the emergence of wound centers and sp...

  • Review
  • Open Access
52 Citations
8,935 Views
14 Pages

The Clinical Trial Landscape for Melanoma Therapies

  • Sonia Wróbel,
  • Małgorzata Przybyło and
  • Ewa Stępień

15 March 2019

(1) Despite many years of research, melanoma still remains a big challenge for modern medicine. The purpose of this article is to review publicly available clinical trials to find trends regarding the number of trials, their location, and interventio...

  • Review
  • Open Access
10 Citations
4,874 Views
14 Pages

25 December 2021

Background: A new type of foods with a health claims notification system, the Foods with Function Claims (FFC), was introduced in Japan in April 2015. This cross-sectional study sought to clarify compliance of clinical trial protocols reported as the...

  • Brief Report
  • Open Access
7 Citations
2,985 Views
8 Pages

Trial Sponsorship and Time to Reporting for Phase 3 Randomized Cancer Clinical Trials

  • Timothy A. Lin,
  • Clifton David Fuller,
  • Vivek Verma,
  • Walker Mainwaring,
  • Andres F. Espinoza,
  • Austin B. Miller,
  • Amit Jethanandani,
  • Dario Pasalic,
  • Prajnan Das and
  • Ethan B. Ludmir
  • + 5 authors

16 September 2020

The pace of clinical trial data generation and publication is an area of interest within clinical oncology; however, little is known about the dynamics and covariates of time to reporting (TTR) of trial results. To assess these, ClinicalTrials.gov wa...

  • Article
  • Open Access
1 Citations
5,164 Views
12 Pages

21 November 2017

Working between the Amos Gitai film One Day You’ll Understand (2008) and the 1987 Klaus Barbie trial against which it is set, the article explores how the trial marked a decisive turning point in France’s relationship to its wartime past. Of Barbie’s...

  • Review
  • Open Access
10 Citations
3,239 Views
12 Pages

The Alliance AMBUSH Trial: Rationale and Design

  • Anita Mahajan,
  • Helen Shih,
  • Marta Penas-Prado,
  • Keith Ligon,
  • Kenneth Aldape,
  • Leland S. Hu,
  • Ashlee R. Loughan,
  • Michael R. Basso,
  • Heather E. Leeper and
  • Evanthia Galanis
  • + 4 authors

14 January 2022

Unlike medulloblastoma (MB) in children, robust prospective trials have not taken place for older patients due to the low incidence of MB in adults and adolescent and young adults (AYA). Current MB treatment paradigms for older patients have been ext...

  • Article
  • Open Access
2 Citations
2,728 Views
15 Pages

14 March 2023

Globally, >80 million new gonorrhea infections occur annually. Here, we assessed barriers to and influences on participation in a gonorrhea clinical trial and the impact of educational intervention. The survey was fielded in the US in March 2022....

  • Article
  • Open Access
19 Citations
10,988 Views
11 Pages

29 March 2022

Resveratrol is a polyphenol that may improve weight loss outcomes in obese individuals. However, assessing the effectiveness of resveratrol supplementations as an appropriate intervention for weight loss in obesity across randomized control trials (R...

  • Article
  • Open Access
2,534 Views
15 Pages

Development and Evaluation of the Clinical Trial HEalth Knowledge and Beliefs Scale (CHEKS)

  • Alicia Chung,
  • Tiffany Donley,
  • Ron D. Hays,
  • Rebecca Robbins,
  • Azizi Seixas and
  • Girardin Jean-Louis

Patient health literacy is vital to clinical trial engagement. Knowledge and beliefs about clinical trials may contribute to patient literacy of clinical trials, influencing engagement, enrollment and retention. We developed and assessed a survey tha...

  • Article
  • Open Access
8 Citations
4,439 Views
10 Pages

The Betel Nut Intervention Trial (BENIT)—A Randomized Clinical Trial for Areca Nut and Betel Quid Cessation: Primary Outcomes

  • Thaddeus A. Herzog,
  • Lynne R. Wilkens,
  • Grazyna Badowski,
  • Ana Joy Pacilan Mendez,
  • Adrian A. Franke,
  • Pallav Pokhrel,
  • Jade S. N. Chennaux,
  • Lynnette F. Tenorio,
  • Patrick P. Sotto and
  • Yvette C. Paulino
  • + 1 author

Background: Areca nut and betel quid (ANBQ) chewing is a widespread carcinogenic habit. The BENIT (ClinicalTrials—NCT02942745) is the first known randomized trial designed for ANBQ chewers. Methods: We compared the intensive behavioral treatmen...

  • Review
  • Open Access
6 Citations
2,894 Views
20 Pages

Trial Design for Cancer Immunotherapy: A Methodological Toolkit

  • Everardo D. Saad,
  • Elisabeth Coart,
  • Vaiva Deltuvaite-Thomas,
  • Leandro Garcia-Barrado,
  • Tomasz Burzykowski and
  • Marc Buyse

21 September 2023

Immunotherapy with checkpoint inhibitors (CPIs) and cell-based products has revolutionized the treatment of various solid tumors and hematologic malignancies. These agents have shown unprecedented response rates and long-term benefits in various sett...

  • Article
  • Open Access
3 Citations
4,090 Views
17 Pages

The primary objective of this randomized trial was to test the effectiveness of the PREDHiCT digital application, which provides educational and supportive navigation to increase willingness to participate in a future clinical trial. The second objec...

  • Review
  • Open Access
2 Citations
2,507 Views
10 Pages

Integrating Systematic Reviews into Supportive Care Trial Design: The Rethinking Clinical Trials (REaCT) Program

  • Bader Alshamsan,
  • Brian Hutton,
  • Michelle Liu,
  • Lisa Vandermeer and
  • Mark Clemons

5 December 2022

Purpose: To review the successes and challenges of integrating systematic reviews (SRs) into the Rethinking Clinical Trials (REaCT) Program. Methods: All REaCT program SRs were evaluated and descriptive summaries presented. Results: Twenty-two SRs ha...

  • Article
  • Open Access
10 Citations
6,599 Views
13 Pages

11 March 2018

This study was designed to analyze the feasibility of economic aspects assuming that the policy of diaper recycling is necessary. With respect to economic feasibility, the collection and transportation of the diaper waste, which accounts for much of...

  • Review
  • Open Access
36 Citations
14,161 Views
52 Pages

Biomarker-Guided Non-Adaptive Trial Designs in Phase II and Phase III: A Methodological Review

  • Miranta Antoniou,
  • Ruwanthi Kolamunnage-Dona and
  • Andrea L. Jorgensen

25 January 2017

Biomarker-guided treatment is a rapidly developing area of medicine, where treatment choice is personalised according to one or more of an individual’s biomarker measurements. A number of biomarker-guided trial designs have been proposed in the past...

  • Review
  • Open Access
21 Citations
17,319 Views
34 Pages

18 September 2024

Inherited retinal diseases (IRDs) encompass a wide spectrum of rare conditions characterized by diverse phenotypes associated with hundreds of genetic variations, often leading to progressive visual impairment and profound vision loss. Multiple natur...

  • Article
  • Open Access
1 Citations
3,573 Views
16 Pages

Motivation to Consent and Adhere to the FORT Randomized Controlled Trial

  • Christine Maheu,
  • Valerie Lok,
  • Jacqueline Galica,
  • Mali Tse,
  • Emma Maltus,
  • Lauriane Giguère,
  • Wing Lam Tock and
  • Sophie Lebel

17 April 2022

The aim of this qualitative study was to identify the motivational factors that influence cancer survivors to participate and adhere to the fear of cancer recurrence (FCR) FORT randomized controlled trial (RCT). Fifteen women diagnosed with breast an...

  • Article
  • Open Access
1,347 Views
13 Pages

Clinical Trial Participation Motivation: Role of Smoking Status

  • Chidubem Egboluche,
  • Rifath Ara Alam Barsha,
  • Shervin Assari and
  • Payam Sheikhattari

11 February 2025

Introduction: The success of clinical trials hinges on the effective recruitment and retention of participants, which remains a persistent challenge. Smoking has well-documented adverse effects on health and is a significant predictor of various chro...

  • Article
  • Open Access
11 Citations
6,571 Views
28 Pages

Whole-Body Photobiomodulation Therapy for Fibromyalgia: A Feasibility Trial

  • Bethany C. Fitzmaurice,
  • Nicola R. Heneghan,
  • Asius T. A. Rayen,
  • Rebecca L. Grenfell and
  • Andrew A. Soundy

29 August 2023

Effective treatment for fibromyalgia (FM) is lacking and further treatment options are needed. Photobiomodulation therapy (PBMT) represents one potential treatment option. Whilst favourable findings have been reported using localised PBMT, no investi...

  • Article
  • Open Access
4 Citations
6,088 Views
21 Pages

9 November 2017

Clinical trial planning of candidate drugs is an important task for pharmaceutical companies. In this paper, we propose two new multistage stochastic programming formulations (CM1 and CM2) to determine the optimal clinical trial plan under uncertaint...

  • Feature Paper
  • Article
  • Open Access
9 Citations
6,216 Views
17 Pages

Recruitment Strategies for a Randomised Controlled Trial Comparing Fast Versus Slow Weight Loss in Postmenopausal Women with Obesity—The TEMPO Diet Trial

  • Michelle S.H. Hsu,
  • Claudia Harper,
  • Alice A. Gibson,
  • Arianne N. Sweeting,
  • John McBride,
  • Tania P. Markovic,
  • Ian D. Caterson,
  • Nuala M. Byrne,
  • Amanda Sainsbury and
  • Radhika V. Seimon

Current research around effective recruitment strategies for clinical trials of dietary obesity treatments have largely focused on younger adults, and thus may not be applicable to older populations. The TEMPO Diet Trial (Type of Energy Manipulation...

  • Review
  • Open Access
6 Citations
3,653 Views
20 Pages

Depending on the patients’ genotype, the same drug may have different efficacies or side effects. With the cost of genomic analysis decreasing and reliability of analysis methods improving, vast amount of genomic information has been made avail...

  • Communication
  • Open Access
21 Citations
6,647 Views
6 Pages

Optimising Clinical Trial Design in Older Cancer Patients

  • Shóna Whelehan,
  • Orlaith Lynch,
  • Niall Treacy,
  • Ciara Gleeson,
  • Andrea Oates and
  • Anita O’Donovan

Cancer is predominantly a disease of older patients, with over half of those aged over 65 years of age being diagnosed with cancer at some stage. Despite comprising a significant proportion of the patients that we see in clinical practice, there is a...

  • Review
  • Open Access
13 Citations
4,456 Views
11 Pages

Trial Design in Critical Care Nutrition: The Past, Present and Future

  • Lee-anne S. Chapple,
  • Emma J. Ridley and
  • Marianne J. Chapman

30 November 2020

The specialty of nutrition in critical care is relatively modern, and accordingly, trial design has progressed over recent decades. In the past, small observational and physiological studies evolved to become small single-centre comparative trials, b...

  • Review
  • Open Access
22 Citations
5,612 Views
18 Pages

Glioblastoma: Emerging Treatments and Novel Trial Designs

  • Vincenzo Di Nunno,
  • Enrico Franceschi,
  • Alicia Tosoni,
  • Lidia Gatto,
  • Raffaele Lodi,
  • Stefania Bartolini and
  • Alba Ariela Brandes

26 July 2021

Management of glioblastoma is a clinical challenge since very few systemic treatments have shown clinical efficacy in recurrent disease. Thanks to an increased knowledge of the biological and molecular mechanisms related to disease progression and gr...

  • Article
  • Open Access
549 Views
18 Pages

Randomized Personalized Trial for Stress Management Compared to Standard of Care

  • Ashley M. Goodwin,
  • Thevaa Chandereng,
  • Heejoon Ahn,
  • Danielle Miller,
  • Stefani Slotnick,
  • Alexandra Perrin,
  • Ying Kuen Cheung,
  • Karina W. Davidson and
  • Mark J. Butler

4 January 2026

Background/Objectives: Psychological stress is a common problem but hard to universally treat. Personalized (N-of-1) trials assess a participant’s response to multiple specific interventions. Though personalized (N-of-1) trials have been used i...

  • Communication
  • Open Access
3 Citations
1,878 Views
10 Pages

Why the MARS2 Trial Does Not Mean the End of All Mesothelioma Surgery

  • David Waller,
  • Rocco Bilancia,
  • Luigi Ventura,
  • Sara Tenconi,
  • Laura Socci and
  • Andrea Bille

21 February 2025

Background/Objectives: The published report of the MARS2 trial suggested that the addition of extended pleurectomy/decortication to chemotherapy for pleural mesothelioma was harmful. Thus, the report goes on, all disease should be considered as unres...

  • Article
  • Open Access
21 Citations
21,367 Views
14 Pages

The Effects of Caffeinated “Energy Shots” on Time Trial Performance

  • Matthew Mark Schubert,
  • Todd Anthony Astorino and
  • John Leal Azevedo Jr.

6 June 2013

An emerging trend in sports nutrition is the consumption of energy drinks and “energy shots”. Energy shots may prove to be a viable pre-competition supplement for runners. Six male runners (mean ± SD age and VO2max: 22.5 ± 1.8 years and 69.1 ± 5.7...

  • Review
  • Open Access
36 Citations
8,204 Views
21 Pages

Clinical Trials in High-Risk Medulloblastoma: Evolution of the SIOP-Europe HR-MB Trial

  • Simon Bailey,
  • Nicolas André,
  • Lorenza Gandola,
  • Maura Massimino,
  • Keith Wheatley,
  • Simon Gates,
  • Victoria Homer,
  • Stefan Rutkowski and
  • Steven C. Clifford

13 January 2022

Medulloblastoma patients receive adapted therapies stratified according to their risk-profile. Favourable, standard, and high disease-risk groups are each defined by the status of clinical and pathological risk factors, alongside an evolving repertoi...

  • Protocol
  • Open Access
329 Views
16 Pages

Back-on-Track: Protocol for Randomised Controlled Feasibility Trial of Behavioural Activation in Farmers with Mood Problems

  • Alison Kennedy,
  • Richard Gray,
  • Martin Jones,
  • Anna Greene,
  • Lauren Mitchell,
  • Meera Senthuren,
  • Suzy Malseed,
  • Feby Savira,
  • Kelly Barnes and
  • Susan Brumby
  • + 1 author

The mental health of people living in farming communities has been identified as an important public health issue. Cumulative exposure to a range of situational factors contributes to heightened risk of poor mental health and suicide. Access to evide...

  • Article
  • Open Access
1 Citations
2,512 Views
7 Pages

Pharmacy Workload in Clinical Trial Management: A Preliminary Complexity Assessment Tool for Sponsored Oncology and Haematology Trials

  • Lorenzo Gasperoni,
  • Carla Masini,
  • Giada Toscano,
  • Alessandro Cafaro,
  • Chiara Zani,
  • Cristina Andrianò,
  • Paolo Silimbani,
  • Caterina Donati,
  • Giorgia Bortolin and
  • Sara Cecco

16 May 2024

Investigational drug services need to be organised in a structured approach, especially for sites with a large number of ongoing clinical trials. The aim of this study was to develop a tool to assess the complexity of pharmacy involvement in a sponso...

  • Article
  • Open Access
5 Citations
4,369 Views
21 Pages

22 March 2023

Background: There is little evidence regarding the efficacy of Regenerative Epidermal Suspension (RES™) management for paediatric partial-thickness burns. The Biobrane® RECELL® Autologous skin Cell suspension and Silver dressings (BRACS...

  • Article
  • Open Access
2,353 Views
29 Pages

A Double-Blind Trial Platform Based on Distributed Ledger Technology

  • Yi-Hong Yeh,
  • Sheng-Chun Hsueh and
  • Tyng-Yeu Liang

28 December 2023

In the pharmaceutical research and development process, the third phase of clinical trials involves double-blind trials to mitigate the influence of human subjective awareness on the experimental results and ensure the efficacy and safety of drugs or...

  • Article
  • Open Access
6 Citations
8,582 Views
18 Pages

Adopting subscription models has become a popular trend in e-commerce. Digital content platforms often use free trials to attract potential subscribers. However, rigorous research on platforms’ free trial strategies is lacking. Our paper aims t...

  • Article
  • Open Access
2 Citations
2,276 Views
13 Pages

Knowledge and Attitudes of Guam Residents towards Cancer Clinical Trial Participation

  • Munirih R. Taafaki,
  • Amy C. Brown,
  • Kevin D. Cassel,
  • John J. Chen,
  • Eunjung Lim and
  • Yvette C. Paulino

(1) Background: Currently there are no cancer clinical trials in Guam, where CHamoru people suffer the highest rates of cancer mortality, and interest to do so is growing. This study investigated the knowledge and attitudes of Guam residents towards...

  • Article
  • Open Access
42 Citations
2,950 Views
7 Pages

Optical Solitons for a Concatenation Model by Trial Equation Approach

  • Ming-Yue Wang,
  • Anjan Biswas,
  • Yakup Yıldırım,
  • Luminita Moraru,
  • Simona Moldovanu and
  • Hashim M. Alshehri

This paper addresses the newly proposed concatenation model by the usage of trial equation approach. The concatenation is a chain model that is a combination of the nonlinear Schrodinger’s equation, Lakshmanan–Porsezian–Daniel model...

  • Article
  • Open Access
1 Citations
1,360 Views
13 Pages

3 January 2025

Background: Childhood nutrition plays an important role in the promotion of long-term health. Introducing solid foods in alignment with the Mediterranean Diet during weaning fosters a preference for healthy foods early in life. However, access to nut...

of 1,134